Bakker Juliet Tammenoms

Filings by Bakker Juliet Tammenoms span 7 companies, the busiest being RxSight, Inc., Axonics, Inc. and Eargo, Inc. Over a trading history stretching from 12 December 2016 to 2 June 2026, the count stands at 65 filings.

On the open market, the record shows 11 purchases worth €29.4M and 12 sales worth €28.6M. Taken together, the purchases exceed the sales by €762k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 share grants.

A typical purchase (the median) is worth €1.7M. On 5 out of 10 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 38% of cases, with a median move of -3.8%. They describe history only and say nothing certain about the share price ahead.

The latest filing, published on 4 June 2026, reports a share grant in Ceribell, Inc. The last insider purchase was made public on 16 October 2024, 753 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.